IPO Headline
Quick Pointers
- Ability to provide integrated engineering solutions with capabilities across the product value chain
- High entry barriers for our competitors due to our technical expertise, capabilities in safety-critical electronics in highly regulated industries and customer engagement
- Robust and industry leading order book with marquee customers, with whom we enjoy sustained and long-standing relationships as their preferred partner
- Manufacturing infrastructure, stringent quality, diverse in-house capabilities and robust supply chain, enabling us to provide high quality end-to end integrated solutions to our customers
- Parentage of our Promoter, Cyient Limited, and a long history of industry expertise, an experienced Board and senior management team
Advertisement
IPO Quick Snapshot
About Company
Cyient DLM established in 1993 is into integrated Electronics Manufacturing Services (EMS) and solutions provider with a focus on the entire life cycle of a product, including design, build and maintain. Our solutions primarily comprise manufacture of: (i) printed circuit board (“PCB”) assembly (“PCBA”), (ii) cable harnesses, and (iii) box builds which are used in safety critical systems such as cockpits, inflight systems, landing systems, and medical diagnostic equipment, which we provide to our clients as B2P or B2S services. Company is having over 22 years of experience in developing high mix, low-to-medium volume highly complex systems.
Customers belong to a diverse range of high-entry-barrier industries that have stringent quality and qualification requirements including Honeywell International Inc. (“Honeywell”), Thales Global Services S.A.S (“Thales”), ABB Inc, Bharat Electronics Limited and Molbio Diagnostics Private Limited. Manufacturing infrastructure comprises three facilities spread across two states in India, at Mysuru, Hyderabad and Bengaluru, with a total manufacturing area of 229,061 sq. ft.
About Industry
The India EMS is a sizeable industry, contributing to 2.2% (USD 20 billion) of the global EMS market in CY2022. India’s EMS industry is the fastest growing among all countries at a CAGR of 32.3% and is expected to contribute 7.0% (USD 80 billion) of the global EMS market in CY2026. The expansion of India's EMS industry is being fuelled by a variety of factors. Significant reasons driving the growth are raising labour costs in other parts of the world and a trend among large OEMs to outsource manufacturing rather than invest in their own infrastructure
Promoter of the company is Cyient Limited (Listed entity). Promoter, together with its nominees holds 92.84% share capital of the company.
IPO Key Details:
IPO Dates
Advertisement
IPO Issue and Subscription Details
Financials
Valuation
IPO Lead Manager Details
IPO Registrar and Transfer Agent (RTA) Details
Check Allotment Status of Mankind Pharma IPO
| Please check below or visit here to check allotment status of IPO |
Source: DRHP, RHP, Company, Company Website | Logo/Images published in the article may be copyright of respective companies.
The objects of the Offer are to (i) carry out the Offer for Sale of 40,058,844 Equity Shares by the Selling Shareholders aggregating to ₹ [●] million; and (ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Company profile and about company
Company profile and about company
Advertisement
Posts
0 Comments